Antibe Therapeutics (ATBPF) News Today → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free ATBPF Stock Alerts $0.22 0.00 (0.00%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 24, 2024 | finance.yahoo.comAntibe Announces Appointment of ReceiverApril 24, 2024 | businesswire.comAntibe Announces Appointment of ReceiverApril 19, 2024 | businesswire.comAntibe Provides Update on CCAA ProceedingsApril 16, 2024 | finance.yahoo.comAntibe Announces TSX Delisting ReviewApril 9, 2024 | businesswire.comAntibe Announces Granting of Initial Order Under Companies' Creditors Arrangement ActApril 9, 2024 | businesswire.comAntibe to File an Application for an Initial Order Under Companies' Creditors Arrangement ActApril 1, 2024 | finance.yahoo.comAntibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by NuanceMarch 20, 2024 | businesswire.comAntibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine MeetingMarch 7, 2024 | businesswire.comAntibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine MeetingMarch 4, 2024 | marketwatch.comAntibe Therapeutics Shares Sink After Arbitration Case LostFebruary 27, 2024 | benzinga.comAntibe Therapeutics Stock (OTC:ATBPF), Insider Trading ActivityFebruary 14, 2024 | finance.yahoo.comAntibe Reports Q3 2024 Interim Financial and Operating ResultsFebruary 14, 2024 | businesswire.comAntibe Reports Q3 2024 Interim Financial and Operating ResultsNovember 13, 2023 | msn.comAntibe Therapeutics reports Q2 resultsNovember 9, 2023 | finance.yahoo.comAntibe Reports PK Results of First Clinical Study of Otenaproxesul’s New FormulationOctober 20, 2023 | finance.yahoo.comIs Antibe Therapeutics (TSE:ATE) In A Good Position To Deliver On Growth Plans?October 18, 2023 | finance.yahoo.comAntibe Initiates First Clinical Study of Otenaproxesul’s New FormulationSeptember 8, 2023 | finance.yahoo.comAntibe Announces Results of 2023 Annual MeetingAugust 14, 2023 | finance.yahoo.comAntibe Reports Q1 2024 Interim Financial and Operating ResultsJune 29, 2023 | finance.yahoo.comAntibe Reports 2023 Year-End Results and Business HighlightsApril 12, 2023 | theglobeandmail.comClosing Bell: Antibe Therapeutics Inc down on Tuesday (ATE)April 6, 2023 | theglobeandmail.comClosing Bell: Antibe Therapeutics Inc up on Wednesday (ATE)March 12, 2023 | finance.yahoo.comAntibe Therapeutics Inc. (ATBPF)February 16, 2023 | markets.businessinsider.comMaxim Group Reaffirms Their Buy Rating on Antibe Therapeutics (ATBPF)February 15, 2023 | markets.businessinsider.comEchelon Wealth Partners Reaffirms Their Buy Rating on Antibe Therapeutics (ATBPF)February 9, 2023 | theglobeandmail.comAntibe Therapeutics: Top 25 Undervalued Dividend Stocks on TSX (ATE)February 7, 2023 | theglobeandmail.comAntibe Therapeutics: Top 10 Undervalued Healthcare Sector Stocks on TSX (ATE)November 22, 2022 | finance.yahoo.comATBPF: On Track to Initiate Phase 2 Trial for Otenaproxesul in 1H23…October 12, 2022 | finance.yahoo.comAntibe Provides Development Update for OtenaproxesulSeptember 9, 2022 | finance.yahoo.comAntibe Announces Results of 2022 Annual MeetingSeptember 6, 2022 | finance.yahoo.comAntibe Academic Collaborator to Present Clinical Data at PAINWeek 2022July 8, 2022 | finance.yahoo.comATE.TO: Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…July 2, 2022 | finance.yahoo.comWill Antibe Therapeutics (TSE:ATE) Spend Its Cash Wisely?June 30, 2022 | finance.yahoo.comAntibe Therapeutics Reports 2022 Year-End Results and Business HighlightsApril 25, 2022 | nz.finance.yahoo.comAntibe Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor ConferenceFebruary 16, 2022 | seekingalpha.comAntibe Therapeutics GAAP EPS of -$0.09February 14, 2022 | finance.yahoo.comAntibe Therapeutics Reports Q3 2022 Interim Financial and Operating ResultsJanuary 28, 2022 | nasdaq.comATBPF Real-Time QuotesDecember 1, 2021 | finance.yahoo.comATE.TO: Development Plan in Place for Otenaproxesul in Acute Pain…October 14, 2021 | msn.comBRIEF-Antibe Therapeutics Provides Update On Otenaproxesul And Expanded Drug PipelineOctober 14, 2021 | finance.yahoo.comAntibe Therapeutics Provides Update on Otenaproxesul and Expanded Drug PipelineAugust 19, 2021 | finance.yahoo.comAntibe Therapeutics Announces Results of 2021 Annual MeetingAugust 17, 2021 | businesswire.comAntibe Therapeutics Reports Q1 2022 Interim Financial and Operating ResultsAugust 4, 2021 | finance.yahoo.comATE.TO: Unexpected Liver Enzyme Elevations Leads to Pause in AME Trial… Get Antibe Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATBPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 Tech Stocks to Buy for 2024 (Ad)The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", ATBPF Media Mentions By Week ATBPF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATBPF News Sentiment▼0.000.73▲Average Medical News Sentiment ATBPF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATBPF Articles This Week▼00▲ATBPF Articles Average Week Get Antibe Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATBPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LIAN News Today PHGE News Today COCP News Today IBIO News Today AIM News Today PHXM News Today BRTX News Today EMMA News Today PCSA News Today NBY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ATBPF) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored